Právní předpis byl sestaven k datu 08.12.2025.
Zobrazené znění právního předpisu je účinné od 27.07.2013.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2014
195/2013 Sb.
195
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 3. xxxxxxxx 2013
x xxxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2014
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx souvisejících xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2014:
1. Xxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx b (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx filamentosum
Pertussis xxxxxxxxx externae proteinum
Diphtheriae xxxxxxxxxx
Xxxxxx anatoxinum xxx.
Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx
Xxxxx poliomyelitidis inactivatum xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2
Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 3
Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx anatoxinum
NEBO
1aa) xxxxxxxxxxx očkovací látka xxxxx záškrtu, xxxxxxxx xxxxx (acelulárni xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum
Haemagglutinum xxxxxxxxxxxx
Xxxxx Poliomyelitidis (xxxxxxxxxxxx)
xxxxx 1 (Mahoney)
typus 2 (XXX-1)
xxxxx 3 (Xxxxxxx)
Xxxxxxxxx xxxxxxxxx hepatitidy B
Haemophilus xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phasphas)
conjugata xxx xxxxxx anatoxinum
1b) očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (DTaP):
Diphtheriae xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx anatoxinum (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xxx. 30 xxxxxxxxxxxxx jednotek
|
|
Tetani anatoxinum
|
min. 40 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxx (XX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx (69xX)
|
&xxxx;
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx X
|
&xxxx;
10 xxxxxxxxxx
|
| &xxxx;
xxx xxxxxxxxx xxxxxxxx
|
&xxxx;
20-40 xxxxxxxxxx
|
1x) xxxxxxxx látka xxxxx xxxxxxx x xxxxxx - divakcína:
Anatoxinum diphtheriae xxxxxxxxxxx ... min. 30 mezinárodních xxxxxxxx
Xxxxxxxxxx xxxxxx purificatum ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx látka proti xxxxxx:
Xxxxxx xxxxxxxxxx ... xxx. 40 mezinárodních xxxxxxxx
1x) očkovací látka xxxxx xxxxxx xxxxxxxxxx X xx 15 xxx xxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx B ... 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx 16 xxx x xxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X ... 20 xxxxxxxxxx
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 infekční dávka xxx buněčnou xxxxxxx50
Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx dávka pro xxxxxxxx xxxxxxx50
Xxxxxxxx xxxxx xxxxxxxxxx (Wistar XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx D jednotek*
Virus xxxxxxxxxxxxx inactivatum typus 2 (MEF-1) ... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Saukett) ... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx proti nákazám xxxxxxxxx Streptococcus pneumoniae x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15B, 17X, 18X, 19A, 19F, 20, 22F, 23X, 33X ... 25 xxxxxxxxxx z xxxxxxx xxxxxxxx
1x) očkovací látka xxxxxxxxxxx proti xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx látka xxxxx záškrtu, xxxxxxxx xxxxx (acelulární forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xx xxxx než 2 xxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxx xxxxxxxxxx
|
&xxxx;
xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxxxxxx
|
&xxxx;
8 mikrogramů
|
|
Pertussis xxxxxxxxxxxxxx filamentosum
|
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
Xxxxx poliomyelitidis xxxxxxxxxxx:
| &xxxx;
xxxxx 1 (xxxx Xxxxxxx)
|
&xxxx;
40 X xxxxxxxx antigenu
|
|
typus 2 (xxxx XXX-1)
|
&xxxx;
8 X xxxxxxxx antigenu
|
|
typus 3 (kmen Xxxxxxx)
|
&xxxx;
32 X xxxxxxxx xxxxxxxx
|
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
|
Difterický xxxxxx
|
&xxxx;
xxxx xxxx rovno 2 xxxxxxxxxxx jednotky (2 Xx)
|
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf)
|
Pertusové xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxx
|
&xxxx;
5 mikrogramů
|
|
Fimbrie xxxx 2+3
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
3 xxxxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)
|
&xxxx;
40 xxxxxxxxxxx X xxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx xxxx 2 (inaktivovaný)
|
8 xxxxxxxxxxx X xxxxxxxx
|
| &xxxx;
Xxxxx poliomyelitis xxxx 3 (inaktivovaný)
|
32 xxxxxxxxxxx D xxxxxxxx
|
1x) xxxxxxxx látka xxxxx xxxxxxxxxxx:
Xxxxxxxx Xxxxxxxx Xxxxxx (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 V.U.*
(kmen Xxxxxxxxxx 1331)
*X.X. = živé xxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx osoby xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 dávce
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx
2x) xxxxxxxx látka proti xxxxxxxxx
Xxxxx xxxxxx inactivatum (xxxx Xxxxxx xxxxxx XX/XX 38 1503-3M xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx jednotek v 1 dávce (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx formuli xxx xxxxxxx:
Xxxxxxxxx A xxxxx inactivatum
3. Antigenní xxxxxxx očkovacích xxxxx xxx mimořádná očkování
3a) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli pro xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
Xxxxxxx:
xxx. MUDr. Xxxxx, XXx., v. x.
Informace
Xxxxxx xxxxxxx č. 195/2013 Xx. xxxxx xxxxxxxxx xxxx 27.7.2013.
Xx dni xxxxxxxx právní předpis xxxxx měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.